Apolipoprotein CI/APOC1 Recombinant Antibody, Biotin Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bsm-62084r-biotin-100uL |
| Product Name | Apolipoprotein CI/APOC1 Recombinant Antibody, Biotin Conjugated |
| Applications |
WB
IHC-P
IHC-F
IP
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Biotin |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human Apolipoprotein C1 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C for 12 months. |
| Target | |
| Gene ID | 341 |
| Swiss Prot | P02654 |
| Subcellular location | Secreted |
| Synonyms | APO C1; Apo CI; APOC 1; ApoC I; APOC1; APOC1B; ApolipoproteinCI. |
| Background | Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. |
| Application Dilution | |
| WB | 1:300-5000 |
| IHC-P | 1:200-400 |
| IHC-F | 1:100-500 |
| IP | 1-2ug |
Frequently asked questions
Which applications is Apolipoprotein CI/APOC1 Recombinant Antibody, Biotin Conjugated (bsm-62084R-Biotin) validated for, and at what dilution?
bsm-62084R-Biotin is validated for WB (1:300-5000); IHC-P (1:200-400); IHC-F (1:100-500); IP (1-2ug). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does Apolipoprotein CI/APOC1 Recombinant Antibody, Biotin Conjugated (bsm-62084R-Biotin) react with?
Tested reactivity: Human.
How should bsm-62084R-Biotin be stored?
Store at -20°C for 12 months. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise Apolipoprotein CI/APOC1 Recombinant Antibody, Biotin Conjugated (bsm-62084R-Biotin)?
KLH conjugated synthetic peptide derived from human Apolipoprotein C1